A serendipitous discovery by academics at The University of Nottingham has shown that a simple illusion can significantly reduce and in some cases even temporarily eradicate arthritic pain in the hand.
By tricking the brain into believing that the painful part of the hand is being stretched or shrunk, the researchers were able to halve the pain felt by 85 per cent of sufferers they tested.
The U.S. Food and Drug Administration approved Actemra (tocilizumab), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in children ages 2 years and older.
Aging often means bad knees, and bad knees often mean osteoarthritis, a common and painful disability that affects more than 20 million Americans.
Tammy Haut Donahue, associate professor in mechanical engineering at Michigan Technological University, is a researcher with an ambitious goal: to prevent osteoarthritis.
The condition results from the breakdown of joint cartilage, which covers the ends of bones. With less cushion, more cartilage is worn away, and a painful rubbing of bone on bone occurs, resulting in osteoarthritis.
Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
While a robust immune response protects the body from foreign invaders, such as bacteria and viruses, an over-activated response causes inflammation, which can lead to such conditions as cardiovascular disease and arthritis.
The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending golimumab (Simponi) for the treatment of psoriatic arthritis. Golimumab joins a list of treatment options already recommended by NICE for this condition.
It's time to get walking! On Sunday, May 15, thousands of people in 24 communities across Canada will come together for The Arthritis Society's Walk To Fight Arthritis, presented by the makers of TYLENOL®. All proceeds will be invested in vital arthritis research and programs for people living with arthritis.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that typically affects the hands and feet, although any joint lined by a synovial membrane may be affected.
More than 4,000 RA patients have been treated with tofacitinib in clinical trials to date. RA affects approximately 1.3 million people in the U.S. and one percent of the adult population worldwide.
The Janus kinase family is one of ten recognized families of non-receptor tyrosine kinases. Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2).
Adding Tofacitinib to standard treatment has been shown to be more effective than standard rheumatoid arthritis treatment alone, according to top-line results of two Phase 3 Trials, pharmaceutical giant Pfizer announced. The company says results details will be presented at a future scientific meeting.
The two trials were called ORAL Standard and ORAL Step.
People with a chronic condition such as diabetes or arthritis may find themselves taking on a more active role in maintaining or improving their own health if there is an ongoing relationship with a primary healthcare (PHC) provider, according to University of British Columbia research.
They say timing is everything, and the saying is also true for those with rheumatic diseases - the most severe of the 100 diseases often lumped under the umbrella term 'arthritis.'